Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis

Animal studies reporting immune checkpoint inhibitors (CPIs) improved host defense and survival during bacterial sepsis provided one basis for phase I CPI sepsis trials. We performed a systematic review and me...

Source: Intensive Care Medicine Experimental - February 4, 2020 Category: Surgery Authors: Lindsay M. Busch, Junfeng Sun, Xizhong Cui, Peter Q. Eichacker and Parizad Torabi-Parizi Tags: Research Source Type: research